Phase II, Single-arm Study of AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2018
At a glance
- Drugs AZD 2811 (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Acronyms SUKSES-N3
- 23 Nov 2018 Status changed from recruiting to discontinued.
- 05 Feb 2018 Status changed from not yet recruiting to recruiting.
- 11 Dec 2017 New trial record